InvestorsHub Logo
Post# of 253171
Next 10
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 227258

Tuesday, 12/17/2019 6:00:28 PM

Tuesday, December 17, 2019 6:00:28 PM

Post# of 253171
MRK—ODAC votes 9-4 in favor of Keytruda monotherapy in second-line NMIBC:

https://finance.yahoo.com/news/fda-oncologic-drugs-advisory-committee-221500044.html

This sBLA has a PDUFA date in Jan 2020; it is based on data from the single-arm KEYNOTE-057 study.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.